Special articleUpcoming Scenarios for the Comprehensive Management of Obstructive Sleep Apnea: An Overview of the Spanish Sleep NetworkEscenarios futuros en el manejo integral de la apnea obstructiva del sueño: perspectiva del Spanish Sleep Network
Introduction
Worldwide, obesity, physical inactivity, and poor diet quality are creating an unsustainable burden of chronic disease. Good sleep quality is also essential for maintaining good health and quality of life. Among the sleep disorders (SD), sleep-disordered breathing (SDB) is one of the most prevalent conditions that compromise sleep quality. The predominant condition associated with SDB is obstructive sleep apnea (OSA), which affects at least 10% of the middle-aged population.1, 2, 3
The management of OSA is challenging the health care system. Diagnosis and treatment of this condition are expensive and require complex tools that are not available in all areas. This chronic and highly prevalent disease has been associated with increased cardiovascular, neurocognitive, metabolic and overall mortality risks, which have contributed to an increasing interest in new strategies for its management.
The SSN is a multidisciplinary research group that has contributed to the identification of OSA impacts and management over the last 20 years. Its main objective has been to promote research in the field of sleep and was developed based on three fundamental pillars: friendship, generosity, and collaborative work. As a result, this network has generated numerous and outstanding contributions in this area that have been pioneering, especially in the development of some of the leading randomized studies in our field. The aim of the 1st World Café, that occurred in March 2017 in Guadalajara (Spain), was to assemble the talent needed to promote the exchange of knowledge and creation of new ideas with the purpose of establishing the main future investigation lines for sleep respiratory medicine for the next 5 years. This meeting attempted to bring together the main scientific societies associated with sleep disorders in Spain: Sociedad Española de Neumología y Cirugía Torácica (SEPAR), Sociedad Española de Sueño (SES), Centro de Investigaciones Biomédicas en Red (CIBER), Federación Española de Medicina del Sueño (FESMES) and a representation of the most relevant Spanish sleep researchers. To assure generational renewal during this meeting, a group of young researchers assumed the lead of the future actions of the SSN. The overall vision was established by consensus as “Sleep as promoter of health and the social impact of sleep disturbances”. Under this focus and with OSA being the most prevalent SD, five research lines were discussed: (1) to incorporate and involve all levels of care; (2) to explore the biological impact of OSA on diseases with high mortality; (3) to cluster and phenotype OSA; (4) to personalize OSA management using current m-Health and smart technologies; and (5) to study the impact of OSA and specific management of the disease in children.
The purpose of this paper is to document the discussions and conclusions from this important meeting (Fig. 1) for dissemination to the scientific community.
Section snippets
Integrated network for the comprehensive management of OSA
In recent years, there has been an increase in the demand for consultations and diagnostic studies in sleep units, which has resulted in long waiting lists and high costs.4, 5 It is unrealistic to assume that adequate management of a chronic and highly prevalent disease such as OSA can be accomplished by sleep specialists alone. There is a need for a new care model for OSA management, namely, an integrated network that involves all healthcare levels. The involvement of primary care in OSA
Biological impact of OSA on comorbidities with high mortality: cardiovascular disease, neurocognitive disease and cancer
SD have been strongly associated with an increased risk for several diseases associated with high mortality and social impacts, such as cardiovascular disease,16 neurocognitive impairment,17 and cancer.18
The presence of OSA leads to pathophysiological mechanisms that include intermittent hypoxia (IH), sleep fragmentation and changes in intrathoracic pressure. These alterations seem to activate inflammation, sympathetic activation, hypercoagulability, endothelial dysfunction, oxidative stress
Big data analysis for the identification of OSA phenotypes
Efficient tools should be used to characterize the population to predict patients at high risk of suffering from the consequences of OSA. One of the current tools is the analysis of large data sets through a big data methodological approach. This type of analysis has had a significant impact on the medical field. It permits accurate modeling of complex diseases and offers new opportunities for innovative clinical applications to subsequently benefit the patient. The increasing availability of
Personalized medicine in OSA
As mentioned, OSA requires personalized medicine to classify the different phenotypes of the disease to prescribe precise and adequate treatment that is targeted to the needs of individual patients on the basis of their genetic, biomarker, phenotypic, or psychosocial characteristics. Efforts to perform unbiased clustering have suggested that additional parameters in the classification approaches may be of value in more clearly defining the subjects.
The gold standard for OSA diagnosis is
OSA in children: current needs and future perspectives
The relevance of OSA in childhood is linked to two fundamental aspects: its prevalence and its important health consequences.43, 44, 45 The prevalence of OSA in children ranges from 0.2 to 4.1%43, 44, 45 and 21.5 to 46.6%46 in obese children. The pathogenesis of childhood OSA is multifactorial.43, 44, 45 Adenotonsillar hypertrophy is the most frequent cause,43, 44, 45 but craniofacial alterations, functional factors, abnormal neurological control and obesity are also implicated. The NANOS-Study
Conclusions
The main conclusions of these five lines of study are summarized as Key points in Table 1.
Conflict of interests
Olga Mediano, Irene Cano-Pumarega, Manuel Sánchez-de-la-Torre, María Luz Alonso-Álvarez, María Fernanda Troncoso, Francisco García-Río, Carlos Egea, Joaquín Durán Cantolla, Joaquín Terán-Santos, Juan Fernando Masa, Josep María Montserrat: none declared.
Ferran Barbé: received a research grant from ResMed Foundation USA, Philips USA, the Health Research Fund, Spanish Ministry of Health, the Spanish Respiratory Society (SEPAR) and Oxigen Salud Spain.
Acknowledgements
To the Sociedad Española de Neumología y Cirugía Torácica (SEPAR), the Sociedad Española de Sueño (SES), the Centro de Investigaciones Biomédicas en Red (CIBER) and the Spanish Sleep Network (SSN) members, especially those who participated in the 1st World Café meeting (Guadalajara, Spain). This work is especially dedicated to our dear friend Joaquin Teran, one of the fathers and architects of the SSN who gave us a life of friendship, affection, enthusiasm and exemplary professionalism.
References (56)
- et al.
Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study
Lancet Respir Med
(2015) - et al.
Screening and assessment for obstructive sleep apnea in primary care
Sleep Med Rev
(2016) - et al.
A network management approach to sleep apnea-hypopnea syndrome: healthcare units
Arch Bronconeumol
(2017) - et al.
Sleep-disordered breathing is independently associated with increased aggressiveness of cutaneous melanoma. A multicentre observational study in 443 patients
Chest
(2018) - et al.
Obstructive sleep apnea is associated with cancer mortality in younger patients
Sleep Med
(2014) - et al.
Phenotypes in obstructive sleep apnea: a definition, examples and evolution of approaches
Sleep Med Rev
(2017) - et al.
Reliability of home respiratory polygraphy for the diagnosis of sleep apnea-hypopnea syndrome: analysis of costs
Arch Bronconeumol
(2008) - et al.
Precision medicine in patients with resistant hypertension and obstructive sleep apnea: blood pressure response to continuous positive airway pressure treatment
J Am Coll Cardiol
(2015) - et al.
Reliability of home respiratory polygraphy for the diagnosis of sleep apnea in children
Chest
(2015) - et al.
Impact of adenotonsillectomy on insulin resistance and lipoprotein profile in nonobese and obese children
Chest
(2016)
Biomarkers associated with obstructive sleep apnea and morbidities: a scoping review
Sleep Med
Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr
Am J Respir Crit Care Med
Increased prevalence of sleep-disordered breathing in adults
Am J Epidemiol
Resources and delays in the diagnosis of sleep apnea-hypopnea syndrome
Arch Bronconeumol
Health care savings: the economic value of diagnostic and therapeutic care for obstructive sleep apnea
J Clin Sleep Med
Primary care vs specialist sleep center management of obstructive sleep apnea and daytime sleepiness and quality of life: a randomized trial
JAMA
Role of primary care in the follow-up of patients with obstructive sleep apnoea undergoing CPAP treatment: a randomised controlled trial
Thorax
Primary care physicians can comprehensively manage sleep apnea patients: a non-inferiority randomized controlled trial
Am J Respir Crit Care Med
A randomized controlled trial of nurse-led care for symptomatic moderate-severe obstructive sleep apnea
Am J Respir Crit Care Med
Effectiveness of sequential automatic-manual home respiratory polygraphy scoring
Eur Respir J
Alternative methods of titrating continuous positive airway pressure: a large multicenter study
Am J Respir Crit Care Med
GESAP trial rationale and methodology: management of patients with suspected obstructive sleep apnea in primary care units compared to sleep units
NPJ Prim Care Respir Med
Management of obstructive sleep apnoea in a primary care vs sleep unit setting: a randomised controlled trial
Thorax
Sleep apnea and cardiovascular disease: an enigmatic risk factor
Circ Res
Neurocognitive function in obstructive sleep apnoea: a meta-review
Respirology
Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea
Eur Respir J
Monocytes inhibit NK activity via TGF-β in patients with obstructive sleep apnoea
Eur Respir J
Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea
Eur Respir J
Cited by (14)
Hypoxic Burden in Obstructive Sleep Apnea: Present and Future
2023, Archivos de BronconeumologiaObstructive sleep apnea in women: We can do more and better
2022, Sleep Medicine ReviewsMultidimensional approach to obstructive sleep apnea
2022, PulmonologyImpact of Obstructive Sleep Apnea on Gestational Diabetes Mellitus
2022, Archivos de BronconeumologiaCitation Excerpt :The number of studies that have evaluated the interactions of OSA with GDM is still scarce, with major heterogeneity in research design, and populations included. Further, larger, multicenter, and more rigorous investigations employing PSG studies in all subjects, with attention to important confounding factors such as obesity, age and ethnic background, are clearly needed to better clarify and characterize the potential complex interrelationships between OSA and GDM,46 in the meantime, practitioners should screen and treat OSA in suspected pregnant women. This research was partially supported by grants from SEPAR-2010-820, Ministerio de Economía y Competitividad (PI10/00495), Ministerio de Ciencia, Innovación y Universidades (PI19/00875), and Programa “Ramon Llull”, contractes per a la Intensificació de l’Activitat Investigadora a l’IdISBa 2020.
Defining the Heterogeneity of Sleep Apnea Syndrome: A Cluster Analysis With Implications for Patient Management
2022, Archivos de BronconeumologiaCitation Excerpt :However, OSA is a very heterogeneous and complex disease6 that is not entirely well defined by this single parameter. Although at present, both the diagnosis and the classification of severity and treatment management of these patients are mostly determined by their AHI,7,8 the heterogeneity of the disease may explain the lack of response to treatment found in some clinical trials.9,10 In recent years, various approaches to better characterize patients with OSA have been developed through cluster analysis.11–17
Plasma profiling reveals a blood-based metabolic fingerprint of obstructive sleep apnea
2022, Biomedicine and PharmacotherapyCitation Excerpt :In the last decade, there have been ongoing efforts to discover and implement alternative approaches to enable early and effective OSA detection. The identification of biological markers in easily accessible biospecimens would be extensively useful for clinicians in this clinical arena [14]. Nevertheless, to date, there is a shortage of simple, reliable and inexpensive indicators with sufficient precision to accurately detect patients with the disease.
- ◊
The authors of the Spanish Sleep Network are included in Appendix A.